Skip to Content

UK Edition. Click here for US version.

SLFP INHALER 25 MICROGRAM/125 MICROGRAM PER METERED DOSE PRESSURISED INHALATION SUSPENSION

Active substance(s): FLUTICASONE PROPIONATE / SALMETEROL XINAFOATE

View full screen / Print PDF » Download PDF ⇩
Transcript
Reason for Update: Name change in DE and NL
Agency Approval Date:
Text Date: 05.08.2015
Text Issue and Draft No.: Issue 6, Draft 1
SPC Issue and Draft No.: Issue 5, Draft 1
CO Number: n/a not marketed

Text in blue is UK specific, i.e. additional to MRP approved QRD text
GSK logo
Package leaflet: Information for the user
SLFP Inhaler
25 microgram/50 microgram per metered dose pressurised inhalation, suspension
25 microgram/125 microgram per metered dose pressurised inhalation, suspension
25 microgram/250 microgram per metered dose pressurised inhalation, suspension
salmeterol/fluticasone propionate
Read all of this leaflet carefully before you start taking this medicine because it contains
important information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,
even if their symptoms and signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
What is in this leaflet:
1.
What SLFP is and what it is used for
2.
What you need to know before you use SLFP
3.
How to use SLFP
4.
Possible side effects
5.
How to store SLFP
6.
Contents of the pack and other information

1 What SLFP is and what it is used for
SLFP contains two medicines, salmeterol and fluticasone propionate:



Salmeterol is a long-acting bronchodilator. Bronchodilators help the airways in the lungs to stay
open. This makes it easier for air to get in and out. The effects last for at least 12 hours.
Fluticasone propionate is a corticosteroid which reduces swelling and irritation in the lungs.

The doctor has prescribed this medicine to help prevent breathing problems such as asthma.
You must use SLFP every day as directed by your doctor. This will make sure that it works properly
in controlling your asthma.
SLFP helps to stop breathlessness and wheeziness coming on. However SLFP should not be used
to relieve a sudden attack of breathlessness or wheezing. If this happens you need to use a fastacting ‘reliever’ (‘rescue’) inhaler, such as salbutamol. You should always have your fast-acting
'rescue' inhaler with you.

1

Reason for Update: Name change in DE and NL
Agency Approval Date:
Text Date: 05.08.2015
Text Issue and Draft No.: Issue 6, Draft 1
SPC Issue and Draft No.: Issue 5, Draft 1
CO Number: n/a not marketed

2 What you need to know before you use SLFP
Do not take SLFP:
If you are allergic to salmeterol, fluticasone propionate or to the other ingredient norflurane (HFA
134a).
Warnings and precautions
Talk to your doctor before using SLFP if you have:
 Heart disease, including an irregular or fast heart beat
 Overactive thyroid gland
 High blood pressure
 Diabetes mellitus (SLFP may increase your blood sugar)
 Low potassium in your blood
 Tuberculosis (TB) now, or in the past, or other lung infections
Other medicines and SLFP
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines. This includes medicines for asthma or any medicines obtained without a prescription. This
is because SLFP may not be suitable to be taken with some other medicines.
Tell your doctor if you are taking the following medicines, before starting to use SLFP:
  blockers (such as atenolol, propranolol and sotalol).  blockers are mostly used for high blood
pressure or other heart conditions.
 Medicines to treat infections (such as ritonavir, ketoconazole, itraconazole and erythromycin).
Some of these medicines may increase the amount of fluticasone propionate or salmeterol in your
body. This can increase your risk of experiencing side effects with SLFP, including irregular heart
beats, or may make side effects worse.
 Corticosteroids (by mouth or by injection). If you have had these medicines recently, this might
increase the risk of this medicine affecting your adrenal gland.
 Diuretics, also known as ‘water tablets’ used to treat high blood pressure.
 Other bronchodilators (such as salbutamol).
 Xanthine medicines. These are often used to treat asthma.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask
your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
SLFP is not likely to affect your ability to drive or use machines.

3 How to use SLFP
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor
or pharmacist if you are not sure.




Use your SLFP every day, until your doctor advises you to stop. Do not take more than the
recommended dose. Check with your doctor or pharmacist if you are not sure.
Do not stop taking SLFP or reduce the dose of SLFP without talking to your doctor first
SLFP should be inhaled through the mouth into the lungs.

2

Reason for Update: Name change in DE and NL
Agency Approval Date:
Text Date: 05.08.2015
Text Issue and Draft No.: Issue 6, Draft 1
SPC Issue and Draft No.: Issue 5, Draft 1
CO Number: n/a not marketed

Adults and adolescents aged 12 years and over
 SLFP 25/50 Inhaler - 2 puffs twice a day
 SLFP 25/125 Inhaler - 2 puffs twice a day
 SLFP 25/250 Inhaler - 2 puffs twice a day
Children 4 to 12 years of age
 SLFP 25/50 Inhaler - 2 puffs twice a day
 SLFP is not recommended for use in children below 4 years of age.
Your symptoms may become well controlled using SLFP twice a day. If so, your doctor may decide to
reduce your dose to once a day. The dose may change to:
 once at night - if you have night-time symptoms
 once in the morning - if you have daytime symptoms.
It is very important to follow your doctor’s instructions on how many puffs to take and how often to
take your medicine.
If you are using SLFP for asthma, your doctor will want to regularly check your symptoms.
If your asthma or breathing gets worse tell your doctor straight away. You may find that you feel
more wheezy, your chest feels tight more often or you may need to use more of your fast-acting
‘reliever’ medicine. If any of these happen, you should continue to take SLFP but do not increase the
number of puffs you take. Your chest condition may be getting worse and you could become seriously
ill. See your doctor as you may need additional treatment.
Instructions for use
 Your doctor, nurse or pharmacist should show you how to use your inhaler. They should check
how you use it from time to time. Not using the SLFP Inhaler properly or as prescribed may mean
that it will not help your asthma as it should.
 The medicine is contained in a pressurised canister in a plastic casing with a mouthpiece.
 There is a counter on the back of the Inhaler which tells you how many doses are left. Each time
you press the canister, a puff of medicine is released and the counter will count down by one.
 Take care not to drop the inhaler as this may cause the counter to count down.
Testing the inhaler
1. When using your inhaler for the first time, test that it is working. Remove the mouthpiece cover by
gently squeezing the sides with your thumb and forefinger and pull apart.

2. To make sure that it works, shake it well, point the mouthpiece away from you and press the
canister to release a puff into the air. Repeat these steps, shaking the inhaler before releasing each
puff, until the counter reads 120. If you have not used your inhaler for a week or more, release two
puffs of medicine into the air.
Using your inhaler
It is important to start to breathe as slowly as possible just before using your inhaler.
1. Stand or sit upright when using your inhaler.
3

Reason for Update: Name change in DE and NL
Agency Approval Date:
Text Date: 05.08.2015
Text Issue and Draft No.: Issue 6, Draft 1
SPC Issue and Draft No.: Issue 5, Draft 1
CO Number: n/a not marketed

2. Remove the mouthpiece cover (as shown in the first picture). Check inside and outside to make
sure that the mouthpiece is clean and free of loose objects.
3. Shake the inhaler 4 or 5 times to ensure that any loose objects are removed and that the contents of
the inhaler are evenly mixed.

4. Hold the inhaler upright with your thumb on the base, below the mouthpiece. Breathe out as far as
is comfortable.

5. Place the mouthpiece in your mouth between your teeth. Close your lips around it. Do not bite.

6. Breathe in through your mouth slowly and deeply. Just after starting to breathe in, press firmly
down on the top of the canister to release a puff of medicine. Do this while still breathing in
steadily and deeply.

7. Hold your breath, take the inhaler from your mouth and your finger from the top of the inhaler.
Continue holding your breath for a few seconds, or as long as is comfortable.

8. Wait about half a minute between taking each puff of medicine and then repeat steps 3 to 7.
9. Afterwards, rinse your mouth with water and spit it out, and/or brush your teeth. This may help to
stop you getting thrush and becoming hoarse.
10. After use always replace the mouthpiece cover straight away to keep out dust. When the
mouthpiece cover is fitted correctly it will ‘click’ into position. If it does not ‘click’ into place,
turn the mouthpiece cover the other way round and try again. Do not use too much force.
Do not rush steps 4, 5, 6 and 7. It is important that you breathe in as slowly as possible just before
using your inhaler. You should use your inhaler whilst standing in front of a mirror for the first few
times. If you see "mist" coming from the top of your inhaler or the sides of your mouth, you should
start again from step 3.
4

Reason for Update: Name change in DE and NL
Agency Approval Date:
Text Date: 05.08.2015
Text Issue and Draft No.: Issue 6, Draft 1
SPC Issue and Draft No.: Issue 5, Draft 1
CO Number: n/a not marketed

As with all inhalers, caregivers should ensure that children prescribed SLFP use correct inhalation
technique, as described above.
If you or your child find it difficult to use the Inhaler, either your doctor or nurse or other healthcare
provider may recommend using a spacer device such as the Volumatic® or AeroChamber Plus® with
your inhaler. Your doctor, nurse, pharmacist or other healthcare provider should show you how to use
the spacer device with your inhaler and how to care for your spacer device and will answer any
questions you may have. It is important that if you are using a spacer device with your inhaler that you
do not stop using it without talking to your doctor or nurse first. It is also important that you do not
change the type of spacer device that you use without talking to your doctor. If you stop using a spacer
device or change the type of spacer device that you use your doctor may need to change the dose of
medicine required to control your asthma. Always talk to your doctor before making any changes to
your asthma treatment
Older children or people with weak hands may find it easier to hold the inhaler with both hands. Put
the two forefingers on top of the inhaler and both thumbs on the bottom below the mouthpiece. A
special device called a Haleraid® may also make it easier.
You should get a replacement when the counter shows the number 020. Stop using the inhaler when
the counter shows 000 as any puffs left in the device may not be enough to give you a full dose. Never
try to alter the numbers on the counter or detach the counter from the metal can.
Cleaning your inhaler
To stop your inhaler blocking, it is important to clean it at least once a week.
To clean your inhaler:
 Remove the mouthpiece cover.
 Do not remove the metal canister from the plastic casing at any time.
 Wipe the inside and outside of the mouthpiece and the plastic casing with a dry cloth or tissue.
 Replace the mouthpiece cover. It will ‘click’ into place when fitted correctly. If it does not ‘click’
into place, turn the mouthpiece cover the other way round and try again. Do not use too much
force.
Do not put the metal canister in water.
If you use more SLFP than you should
It is important to use the inhaler as instructed. If you accidentally take a larger dose than
recommended, talk to your doctor or pharmacist. You may notice your heart beating faster than usual
and that you feel shaky. You may also have dizziness, a headache, muscle weakness and aching joints.
If you have used larger doses for a long period of time, you should talk to your doctor or pharmacist
for advice. This is because larger doses of SLFP may reduce the amount of steroid hormones produced
by the adrenal gland.
If you forget to use SLFP
Do not take a double dose to make up for a forgotten dose. Just take your next dose at the usual time.
If you stop using SLFP
It is very important that you take your SLFP every day as directed. Keep taking it until your doctor
tells you to stop. Do not stop or suddenly reduce your dose of SLFP. This could make your
breathing worse.

5

Reason for Update: Name change in DE and NL
Agency Approval Date:
Text Date: 05.08.2015
Text Issue and Draft No.: Issue 6, Draft 1
SPC Issue and Draft No.: Issue 5, Draft 1
CO Number: n/a not marketed

In addition, if you suddenly stop taking SLFP or reduce your dose of SLFP this may (very rarely)
cause you to have problems with your adrenal gland (adrenal insufficiency) which sometimes causes
side effects.
These side effects may include any of the following:
 Stomach pain
 Tiredness and loss of appetite, feeling sick
 Sickness and diarrhoea
 Weight loss
 Headache or drowsiness
 Low levels of sugar in your blood
 Low blood pressure and seizures (fits)
When your body is under stress such as from fever, trauma (such as a car accident), infection, or
surgery, adrenal insufficiency can get worse and you may have any of the side effects listed above.
If you get any side effects, talk to your doctor or pharmacist. To prevent these symptoms occurring,
your doctor may prescribe extra corticosteroids in tablet form (such as prednisolone).
If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.

4 Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. To reduce
the chance of side effects, your doctor will prescribe the lowest dose of SLFP to control your asthma.
Allergic reactions: you may notice your breathing suddenly gets worse immediately after using
SLFP. You may be very wheezy and cough or be short of breath. You may also notice itching, a rash
(hives) and swelling (usually of the face, lips, tongue or throat) , or you may suddenly feel that your
heart is beating very fast or you feel faint and light headed (which may lead to collapse or loss of
consciousness). If you get any of these effects or if they happen suddenly after using SLFP, stop
using SLFP and tell your doctor straight away. Allergic reactions to SLFP are uncommon (they
affect less than 1 person in 100).
Other side effects are listed below:
Very Common (affects more than 1 person in 10)
 Headache - this usually gets better as treatment continues.
 Increased number of colds have been reported in patients with COPD.
Common (affects less than 1 person in 10)
 Thrush (sore, creamy-yellow, raised patches) in the mouth and throat. Also sore tongue and
hoarse voice and throat irritation. Rinsing your mouth out with water and spitting it out
immediately and/or brushing your teeth after taking each dose of your medicine may help. Your
doctor may prescribe an anti-fungal medication to treat the thrush.
 Aching, swollen joints and muscle pain.
 Muscle cramps.

6

Reason for Update: Name change in DE and NL
Agency Approval Date:
Text Date: 05.08.2015
Text Issue and Draft No.: Issue 6, Draft 1
SPC Issue and Draft No.: Issue 5, Draft 1
CO Number: n/a not marketed

The following side effects have also been reported in patients with Chronic Obstructive Pulmonary
Disease (COPD):
 Pneumonia and bronchitis (lung infection). Tell your doctor if you notice any of the following
symptoms: increase in sputum production, change in sputum colour, fever, chills, increased cough,
increased breathing problems.
 Bruising and fractures.
 Inflammation of sinuses (a feeling of tension or fullness in the nose, cheeks and behind the eyes,
sometimes with a throbbing ache).
 A reduction in the amount of potassium in the blood (you may get an uneven heart beat, muscle
weakness, cramp).
Uncommon (affects less than 1 person in 100)
 Increases in the amount of sugar (glucose) in your blood (hyperglycaemia). If you have diabetes,
more frequent blood sugar monitoring and possibly adjustment of your usual diabetic treatment
may be required.
 Cataract (cloudy lens in the eye).
 Very fast heart beat (tachycardia).
 Feeling shaky (tremor) and fast or uneven heart beat (palpitations) - these are usually harmless and
get less as treatment continues.
 Chest pain.
 Feeling worried (this effect mainly occurs in children).
 Disturbed sleep.
 Allergic skin rash.
Rare (affects less than 1 person in 1000)
 Breathing difficulties or wheezing that get worse straight after taking SLFP. If this happens
stop using your SLFP inhaler. Use your fast-acting ‘reliever’ inhaler to help your breathing and
tell your doctor straight away.
 SLFP may affect the normal production of steroid hormones in the body, particularly if you have
taken high doses for long periods of time. The effects include:
 Slowing of growth in children and adolescents
 Thinning of the bones
 Glaucoma
 Weight gain
 Rounded (moon shaped) face (Cushing’s Syndrome).
Your doctor will check you regularly for any of these side effects and make sure you are taking the
lowest dose of SLFP to control your asthma.
 Behavioural changes, such as being unusually active and irritable (these effects mainly occur in
children).
 Uneven heart beat or heart gives an extra beat (arrhythmias). Tell your doctor, but do not stop
taking SLFP unless the doctor tells you to stop.
 A fungal infection in the oesophagus (gullet), which might cause difficulties in swallowing.
Frequency not known, but may also occur:
 Depression or aggression. These effects are more likely to occur in children.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet.
You can also report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the
safety of this medicine.
7

Reason for Update: Name change in DE and NL
Agency Approval Date:
Text Date: 05.08.2015
Text Issue and Draft No.: Issue 6, Draft 1
SPC Issue and Draft No.: Issue 5, Draft 1
CO Number: n/a not marketed

5 How to store SLFP






Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton after EXP.
The expiry date refers to the last day of that month.
Do not store above 25C.
The canister contains a pressurised liquid. Do not expose to temperatures higher than 50°C,
protect from direct sunlight. Do not pierce or burn the canister even when empty.
As with most inhaled medicinal products in pressurised canisters, the therapeutic effect of this
medicinal product may decrease when the canister is cold.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to
throw away medicines you no longer use. These measures will help protect the environment.

6 Contents of the pack and other information
What SLFP contains
 Each metered dose contains 25 micrograms of salmeterol (as salmeterol xinafoate) and 50, 125 or
250 micrograms of fluticasone propionate.
 The other ingredient is propellant: norflurane (HFA 134a).
What SLFP looks like and contents of the pack
 SLFP Inhaler is supplied to you in a metered dose inhaler which delivers your medicine in a
pressurised suspension for you to inhale through your mouth into your lungs.
 The pressurised canister contains a white to off white suspension for inhalation.
 The canisters are fitted into a plastic casing incorporating a mouthpiece and fitted with dustcaps.
The devices are packed in cartons of 1, 3 or 10 Inhalers. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Glaxo Wellcome UK Ltd
Stockley Park West
Uxbridge
Middlesex, UB11 1BT
Manufacturer:
Glaxo Wellcome Production
Zone Industrielle No.2, 23 Rue Lavoisier, La Madeleine, 27000 Evreux, France.
Tel: +33 2 3223 5500; Fax: +33 2 3223 5558
or
Glaxo Wellcome S.A.
Avenida de Extremadura, 3 - 09400, Aranda de Duero, Burgos, Spain
Tel: +34 947 529 700; Fax: +34 947 529 800
or
GlaxoWellcome GmbH and Co KG
Industriestrasse 32-36
8

Reason for Update: Name change in DE and NL
Agency Approval Date:
Text Date: 05.08.2015
Text Issue and Draft No.: Issue 6, Draft 1
SPC Issue and Draft No.: Issue 5, Draft 1
CO Number: n/a not marketed

D-23843, Bad Oldesloe, Germany
This medicinal product is authorised in the Member States of the EEA under the following
names:
France
Germany
Hungary
The Netherlands
United Kingdom

Fluticasone/Salmeterol GSK
Salmeterol/Fluticasonpropionat Dosier-Aerosol Cascan
Thoreus Evohaler
Salmeterol/fluticasonpropionaat Inhalator GSK
SLFP Inhaler

Other formats:
To listen to or request a copy of this leaflet in Braille, large print or audio please call free of charge:

0800 198 5000 (UK Only)
Please be ready to give the following information:
Product name
Reference number

Salmeterol/Fluticasone Propionate Inhaler
10949/0376

This is a service provided by the Royal National Institute of Blind People.
This leaflet was last revised in August 2015.
Haleraid and Volumatic are registered trademarks of the GSK group of companies.
AeroChamber Plus is a registered trademark of Trudell Medical International.
© 2015 GSK group of companies. All rights reserved.

9

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide